Atlas Trials

TScan Therapeutics, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TScan Therapeutics, Inc.

RecordFirmDate
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (NCT07702578)TScan Therapeutics, Inc.2026-06-18
A Long Term Follow-up Study of TScan TCR-T Products (NCT06976736)TScan Therapeutics, Inc.2025-09-09
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (NCT05973487)TScan Therapeutics, Inc.2024-05-06
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors (NCT05812027)TScan Therapeutics, Inc.2023-06-26
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (NCT05473910)TScan Therapeutics, Inc.2022-11-01
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. (NCT05230186)TScan Therapeutics, Inc.2021-02-26
Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors (NCT04680416)TScan Therapeutics, Inc.2020-12-17
Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes (NCT04397900)TScan Therapeutics, Inc.2020-04-09

Track TScan Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.